Junel Fe 24

Junel Fe 24

Generic Name

Junel Fe 24

Mechanism

  • Reduces iron deficiency by supplying elemental iron that is absorbed in the duodenum.
  • Fe³⁺ is reduced to Fe²⁺ by duodenal ferric reductases (steap3), enabling transport through the divalent metal transporter‑1 (DMT‑1) into enterocytes.
  • Inside enterocytes, iron is stored as ferritin or secreted into circulation via ferroportin, bound to transferrin for delivery to erythroid precursors.
  • The resulting increase in serum iron supports hemoglobin synthesis and RBC maturation.

---

Pharmacokinetics

  • Absorption: ~2‑5 % of oral dose reaches systemic circulation; peak plasma levels within *1–2 h* after ingestion.
  • Distribution: Binds transferrin; stored mainly in bone marrow, spleen, and liver.
  • Metabolism/Elimination: Little hepatic metabolism; iron is incorporated into hemoglobin or ferritin; excess is excreted via the gut lumen. Elimination half‑life ≈ *30 min* for absorbed iron, but iron stores persist and are metabolically turned over over weeks–months.
  • Factors affecting absorption:
  • Inhibition by calcium, phytates, polyphenols, and high‑fat meals.
  • Enhancement by vitamin C (ascorbic acid) and citrate.

---

Indications

  • Prevention of iron‑deficiency anemia in at-risk populations (e.g., menstruating women, pregnancy, infancy, vegetarians).
  • Maintenance therapy for patients with mild iron‑deficiency anemia when higher elemental doses are not required.
  • Adjunct in dietary iron supplementation for chronic disease or malabsorption when low-dose iron is preferred to reduce gastrointestinal toxicity.

---

Contraindications

Contraindications
• Known hemochromatosis or iron overload disorder.
Iron‑related hypersensitivity (e.g., allergic reaction to ferrous compounds).
• Acute hemolysis or hemoglobinopathies requiring high-dose iron replacement.

Warnings
• Gastrointestinal irritation (nausea, constipation) – take with a small amount of liquid or food.
• Black or tarry stools – benign side effect but may conceal GI bleeding; evaluate if persistent or accompanied by melena.
• Oxidative stress potential in patients with chronic inflammatory disease; avoid excessive dosing.
• Pregnancy: safe at recommended doses; high doses may increase oxidative stress.

---

Dosing

  • Adult & adolescent: 1 tablet *once daily*, preferably in the morning with water.
  • Infants 6–12 mo.: 1 tablet *every 12 h* (if physician prescribes a low‑dose formulation).
  • Patients with iron‑deficiency anemia requiring higher elemental iron: 24 mg per tablet is generally insufficient; consider higher‑dose preparations (e.g., 100–200 mg elemental iron) under supervision.
  • Take with vitamin C to enhance absorption; avoid concurrent calcium‑rich foods or supplements at the same time.
  • Chewable tablets (if available) can improve taste and tolerance in children.

---

Adverse Effects

Common (≥10 %)
• Gastrointestinal: nausea, abdominal discomfort, constipation, diarrhea.
• Darkened stools.
• Headache, mild dizziness.

Serious (rare)
• Severe GI bleeding or ulceration (especially in patients with peptic ulcer disease).
• Hypersensitivity reactions: rash, angioedema.
• Hemolysis in G6PD deficiency if high‑dose formulations are mistakenly taken.

---

Monitoring

ParameterFrequencyRationale
Hemoglobin/HematocritBaseline, 2–4 wk, then 6 wkAssess efficacy, dose adequacy
Serum ferritinBaseline, 3 moEstimate iron stores
Transferrin SaturationBaseline, 3 moEvaluate iron mobilization
Serum ironOptionalMonitor absorption & overload
Liver enzymesBaseline for patients with liver diseaseIron can stimulate oxidative stress
Clinical assessmentEach clinic visitGI tolerance, compliance

--

Clinical Pearls

  • Vitamin C synergy: Combining 50 mg vitamin C with Junel Fe 24 can boost absorption up to 50 % – ideal for patients with marginal compliance or those eating a calcium‑rich diet.
  • Timing matters: Taking the tablet *30 min before breakfast* can improve tolerability while avoiding interaction with iron‑blocking foods.
  • Steady dose: A low‑dose daily regime (24 mg) reduces GI adverse events compared with intermittent high‑dose protocols, making it a preferable choice for maintenance therapy.
  • Taste & compliance: If the tablet’s metallic taste is problematic, administer with a small amount of juice or as chewable (if available) to enhance adherence.
  • Screen for hypersensitivity: Prior to therapy, review patient history for reactions to oral iron formulations; if uncertain, perform a skin test before initiating therapy in high‑risk individuals.

--
Key Takeaway – Junel Fe 24 is a low‑dose, well-tolerated oral iron supplement suited for preventive use and mild iron‑deficiency management. Optimize absorption with vitamin C, avoid calcium‑rich meals, and monitor hematologic indices to ensure effective and safe therapy.

Medical & AI Content Disclaimers
Medical Disclaimer: Medical definitions are provided for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

AI Content Disclaimer: Some definitions may be AI-generated and may contain inaccuracies. Always verify with authoritative medical references.

Scroll to Top